Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpha-cyanoacrylate is an organic compound and the parent structure of the cyanoacrylate family, which are strong, fast-acting adhesives widely used in industrial, medical, and household applications. In medicine, cyanoacrylates—including derivatives such as ethyl cyanoacrylate and 2-octyl cyanoacrylate—are used as tissue adhesives for wound closure and surgical procedures. These adhesives polymerize rapidly in the presence of moisture to form a strong bond with biological tissues. The mechanism of action involves rapid anionic polymerization upon contact with water or tissue fluids, resulting in a durable adhesive layer that can close wounds or bond medical devices[4][1][2]. Alpha-cyanoacrylates have been studied for their biocompatibility and are subject to regulatory standards for use in humans[5]. They offer advantages such as faster wound closure compared to sutures and reduced risk of needle-stick injuries but may cause local irritation or allergic reactions[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha-cyanoacrylate.